Skip to main content

Vanderbilt Institute of Chemical Biology Archives

Founders’ Celebration for Institute of Chemical Biology set for March 28

Mar. 22, 2018—The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator.

Read more


A spicy finding

Jan. 16, 2018—Vanderbilt researchers have discovered that curcumin — the active ingredient in the spice turmeric — needs to be metabolically activated to exert anti-inflammatory effects.

Read more


Vanderbilt mourns loss of pharmacologist H. Alex Brown

Jul. 26, 2017—H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology at Vanderbilt University School of Medicine, died from cancer Tuesday, July 25, at his home. He was 56.

Read more


Oxidative stress in tumors

May. 18, 2017—Vanderbilt investigators have developed a new method for measuring oxidative stress in human tumors, which provides insight into cancer development.

Read more


Brown named interim director of Institute of Chemical Biology

Nov. 3, 2016—H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).

Read more


Transcription factor evolution

Aug. 11, 2016—Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.

Read more


How strep grabs on to platelets

Apr. 20, 2016—New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.

Read more


Purdue’s Low set for next Flexner Discovery Lecture

Apr. 7, 2016—Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14.

Read more


Nobel laureate’s lecture highlights impact of science

Jan. 28, 2016—“Stay with science,” Nobel laureate Peter Agre, M.D., advised dozens of medical and graduate students who attended his lecture at Vanderbilt University Medical Center last week. “It will take you to fascinating places.”

Read more


‘Science diplomacy’ focus of Nobel laureate Agre’s Discovery Lecture

Jan. 14, 2016—Peter Agre, M.D., a Nobel laureate who advocates the use of medical science to advance international diplomacy, will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Jan. 21, in room 208 Light Hall.

Read more


The yin and yang of COX-2

Oct. 2, 2015—New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.

Read more


Lit up COX-2 cancer probe

Jun. 17, 2015—A new imaging probe developed by Vanderbilt investigators enhances tumor visibility and has broad applications in diagnosing and monitoring patients with cancer.

Read more


Recent Stories from VUMC News and Communications Publications

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

Vanderbilt Medicine

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Hope

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

Momentum

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

more